Company News

Share this article:

AstraZeneca (AZ) announced a partnership with Astellas Pharma to co-promote AZ's Symbicort Turbuhaler in Japan. Astellas will make an upfront payment of $31.5 million to AZ, plus additional milestone payments depending on sales.

inVentiv Health announced the addition of a Japanese office in Tokyo – inVentiv Japan – to be led by Dan Feldman. The office will provide outsourced sales solutions and communications in the pharmaceutical and healthcare space, according to a release.


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.